.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Baxter
Deloitte
Julphar
Argus Health
Teva
Fuji
Mallinckrodt
Accenture
UBS

Generated: June 25, 2017

DrugPatentWatch Database Preview

FLUXID Drug Profile

« Back to Dashboard

What is the patent landscape for Fluxid, and what generic Fluxid alternatives are available?

Fluxid is a drug marketed by Ucb Inc and is included in one NDA. There are two patents protecting this drug.

This drug has thirteen patent family members in nine countries.

The generic ingredient in FLUXID is famotidine. There are eighteen drug master file entries for this compound. One hundred and twenty-three suppliers are listed for this compound. Additional details are available on the famotidine profile page.

Summary for Tradename: FLUXID

Patents:2
Applicants:1
NDAs:1
Bulk Api Vendors: see list66
Patent Applications: see list5,281
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLUXID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc
FLUXID
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL021712-001Sep 24, 2004DISCNNoNo6,221,392► SubscribeY ► Subscribe
Ucb Inc
FLUXID
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL021712-002Sep 24, 2004DISCNNoNo6,024,981► SubscribeY ► Subscribe
Ucb Inc
FLUXID
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL021712-001Sep 24, 2004DISCNNoNo6,024,981► SubscribeY ► Subscribe
Ucb Inc
FLUXID
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL021712-002Sep 24, 2004DISCNNoNo6,221,392► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: FLUXID

Country Document Number Estimated Expiration
Australia726336► Subscribe
Japan2012162558► Subscribe
Spain2525720► Subscribe
European Patent Office2266538► Subscribe
Portugal2147669► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Moodys
Fuji
Fish and Richardson
Covington
AstraZeneca
Federal Trade Commission
Medtronic
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot